Interaction between nitric oxide and angiotensin II in the endothelium: role in atherosclerosis and hypertension
- 1 March 2006
- journal article
- review article
- Published by Ovid Technologies (Wolters Kluwer Health) in Journal of Hypertension
- Vol. 24 (1), S45-S50
- https://doi.org/10.1097/01.hjh.0000220406.46246.f2
Abstract
Although there is overwhelming evidence that hypertension promotes atherosclerosis, the relative contribution and/or interaction of vasoactive and hemodynamic factors remain undefined. Endothelial dysfunction complicates hypertension and is a precursor of atherosclerosis. It is characterized by a reduction in the bioavailability of vasodilators, particularly nitric oxide, and an increase in the activity of vasoconstrictors, including angiotensin (Ang) II and reactive oxygen species (ROS). Nitric oxide antagonizes the vasoconstrictive and pro-atherosclerotic effects of Ang II, whereas Ang II decreases nitric oxide bioavailability by promoting oxidative stress. The present review will focus on the interaction among nitric oxide, Ang II, and ROS in the endothelium and will examine their role in vascular tone and atherogenesis. In this context, studies from our laboratory will be reviewed demonstrating that salt-sensitive hypertension is a vascular diathesis characterized by a local activation of Ang II and NAD(P)H oxidase-derived ROS in the setting of insufficient nitric oxide. In hypertensive Dahl salt-sensitive rats, a paradigm of human salt-sensitive hypertension, inhibition of Ang II type 1 receptor or NAD(P)H oxidase-derived ROS prevented the development of endothelial dysfunction, upregulation of pro-atherogenic molecules, and vascular ROS generation, independently of blood pressure. Salt sensitivity, an independent risk factor for increased cardiovascular morbidity and mortality, affects approximately 50% of hypertensives. Our studies suggest that, in salt-sensitive hypertension, atherogenesis is more closely linked to oxidative stress than to the hemodynamic stress of hypertension. To prevent or arrest atherosclerosis, antihypertensive therapy should aim at restoring the homeostatic balance between vasoactive factors in the vascular wall.Keywords
This publication has 50 references indexed in Scilit:
- Reduced NAD(P)H Oxidase in Low Renin HypertensionHypertension, 2006
- Angiotensin II and the EndotheliumHypertension, 2005
- Angiotensin II type 1 receptor blockers reduce tissue factor activity and plasminogen activator inhibitor type-1 antigen in hypertensive patients: a randomized, double-blind, placebo-controlled studyAtherosclerosis, 2004
- Atorvastatin Prevents End-Organ Injury in Salt-Sensitive HypertensionHypertension, 2004
- Dysfunction of Endothelial Nitric Oxide Synthase and AtherosclerosisArteriosclerosis, Thrombosis, and Vascular Biology, 2004
- In Salt-Sensitive Hypertension, Increased Superoxide Production Is Linked to Functional Upregulation of Angiotensin IIHypertension, 2003
- NAD(P)H Oxidase Mediates Angiotensin II–Induced Vascular Macrophage Infiltration and Medial HypertrophyArteriosclerosis, Thrombosis, and Vascular Biology, 2003
- Enhancement of Intrarenal Angiotensinogen in Dahl Salt-Sensitive Rats on High Salt DietHypertension, 2003
- Superoxide Production and Expression of Nox Family Proteins in Human AtherosclerosisCirculation, 2002
- Chronic Inhibition of Nitric Oxide Synthesis Causes Coronary Microvascular Remodeling in RatsHypertension, 1995